Expert Rev Mol Diagn. 2008;8(5):579-585. Quite a few tumor markers (CEA, CA 19-9, AFP, SCC, CA 72-4.) have already been established in diagnosis and/or surveillance of malignant diseases of the GI ...

In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...

The sensitivity of cells to a drug candidate is determined in viability assays and correlated to the cancer gene mutation status of the cell lines. This type of study reveals novel markers of drug ...

Consequently, there is strong demand for a more reliable prognostic marker. Addressing this need, a research team from the Gynecological Cancer Center at Korea University Guro Hospital conducted a ...

Of more than 2,500 microRNAs in blood, 100 especially common types were selected to combine with a conventional tumor marker to create a diagnostic model. The data of the microRNAs and the cancer ...